Intranasal administration of miR-145–5p antagomir to mice reversed HDM-induced decrease in KIF3A (expressed in airway epithelial cells), reduced inflammatory response in the lung, and ultimately, modulated asthma phenotypes (39). The gene discussed is KIF3A; the disease is asthma.